Common allergy medication’s risks outweigh its usefulness, experts say
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
Are Breast Cancer Survivors Vulnerable to Dementia?
Despite concerns about cognitive decline after cancer treatment, most breast cancer survivors show no increased risk of developing…